NeuroDerm CEO to Present at the Jefferies Global Healthcare Conference on June 7, 2017
May 30, 2017 11:04 am UTC| Business
REHOVOT, Israel, May 30, 2017 -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders, today announced that CEO Oded S....
NeuroDerm CEO to Present at the Jefferies Global Healthcare Conference on June 7, 2017
May 30, 2017 11:04 am UTC| Business
REHOVOT, Israel, May 30, 2017 -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders, today announced that CEO Oded S....
NeuroDerm CEO to Present at the Jefferies Global Healthcare Conference on June 7, 2017
May 30, 2017 11:04 am UTC| Business
REHOVOT, Israel, May 30, 2017 -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders, today announced that CEO Oded S....
May 30, 2017 11:03 am UTC| Business
DURHAM, N.C., May 30, 2017 -- GeneCentric Therapeutics, Inc., a precision medicine company dedicated to accelerating drug development by redefining the advanced classification of cancers, today announced the...
Husky to Present Five-Year Growth Plan at Investor Day
May 30, 2017 11:03 am UTC| Business
Five-Year Plan Highlights1 Key Metrics20172017 – 2021F CAGR22021FProduction (mboe/day)320 - 3354.8%390-400Funds from operations3 $3.3B9%~$4.8BFree cash flow3$750M12%~$1.2BUpstream operating cost/bbl$14.25$12Downstream...
May 30, 2017 11:03 am UTC| Business
DURHAM, N.C., May 30, 2017 -- GeneCentric Therapeutics, Inc., a precision medicine company dedicated to accelerating drug development by redefining the advanced classification of cancers, today announced the...
May 30, 2017 11:03 am UTC| Business
DURHAM, N.C., May 30, 2017 -- GeneCentric Therapeutics, Inc., a precision medicine company dedicated to accelerating drug development by redefining the advanced classification of cancers, today announced the...